Julian A Bonner
Director, Clinical Programs @Medipost Inc
Signup · Get unlimited contacts
WORK HISTORY
Director, Clinical Programs @Medipost Inc
Cambridge, MA, US
Founded in 2012, MEDIPOST, Inc. is a leading commercial-stage biotechnology company specializing in the development of umbilical cord-derived stem cell therapies to treat inflammation-driven degenerative diseases. The company\'s flagship product, CARTISTEM®, is the world\'s first allogeneic stem cell therapy for knee osteoarthritis (OA), approved in Korea in 2012 and used to treat over patients. Following its Phase 1/2a U.S. clinical trial, MEDIPOST, Inc. is now preparing its IND to begin a Phase study.
EDUCATION
University of Sunderland
BSc (Hons), Applied Physiology
ABOUT JULIAN A BONNER
Accomplished Clinical professional experienced in managing International Clinical Research Trials in more than 40 countries.As an Executive Leader, I enhance client, team and vendor relations, develop and implement operational plans & risk management strategies, and improve processes.Demonstrated history of Executive Oversight and Line Management, identifying, leading and retaining high-functioning, stable teams and providing cross-functional and departmental support. Experienced in running Phase I through IV clinical studies in small and large pharmaceutical, biotech and contract research organizations. Multiple therapeutic area experience including Oncology, CNS, Musculoskeletal, Cardiovascular, Endocrinology, Respiratory, Rare Disease and Phase I Healthy Volunteer.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.